nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—CYP2D6—Fingolimod—multiple sclerosis	0.103	0.244	CbGbCtD
Donepezil—CYP3A4—Fingolimod—multiple sclerosis	0.0652	0.155	CbGbCtD
Donepezil—CYP3A4—Methylprednisolone—multiple sclerosis	0.042	0.1	CbGbCtD
Donepezil—HTR2A—trigeminal nucleus—multiple sclerosis	0.0337	0.298	CbGeAlD
Donepezil—CYP3A4—Triamcinolone—multiple sclerosis	0.0319	0.0758	CbGbCtD
Donepezil—CYP3A4—Mitoxantrone—multiple sclerosis	0.0307	0.0729	CbGbCtD
Donepezil—CYP2C9—Dexamethasone—multiple sclerosis	0.0273	0.065	CbGbCtD
Donepezil—CYP3A4—Betamethasone—multiple sclerosis	0.0273	0.065	CbGbCtD
Donepezil—CYP3A4—Prednisolone—multiple sclerosis	0.027	0.0642	CbGbCtD
Donepezil—CYP3A4—Prednisone—multiple sclerosis	0.0255	0.0606	CbGbCtD
Donepezil—CYP2D6—Dexamethasone—multiple sclerosis	0.025	0.0595	CbGbCtD
Donepezil—CYP3A4—Dexamethasone—multiple sclerosis	0.0159	0.0378	CbGbCtD
Donepezil—HTR2A—trigeminal nerve—multiple sclerosis	0.00885	0.0782	CbGeAlD
Donepezil—HRH3—brainstem—multiple sclerosis	0.00718	0.0634	CbGeAlD
Donepezil—Moexipril—SLC15A2—multiple sclerosis	0.00663	1	CrCbGaD
Donepezil—HTR2A—pons—multiple sclerosis	0.00623	0.0551	CbGeAlD
Donepezil—HTR2A—pineal body—multiple sclerosis	0.00445	0.0393	CbGeAlD
Donepezil—HTR2A—peripheral nervous system—multiple sclerosis	0.00415	0.0366	CbGeAlD
Donepezil—HRH3—nervous system—multiple sclerosis	0.00376	0.0332	CbGeAlD
Donepezil—HRH3—central nervous system—multiple sclerosis	0.00362	0.032	CbGeAlD
Donepezil—HRH3—cerebellum—multiple sclerosis	0.00354	0.0312	CbGeAlD
Donepezil—HTR2A—nerve—multiple sclerosis	0.00323	0.0286	CbGeAlD
Donepezil—HRH3—brain—multiple sclerosis	0.00287	0.0254	CbGeAlD
Donepezil—ACHE—medulla oblongata—multiple sclerosis	0.00271	0.0239	CbGeAlD
Donepezil—ACHE—midbrain—multiple sclerosis	0.00247	0.0219	CbGeAlD
Donepezil—ACHE—spinal cord—multiple sclerosis	0.00241	0.0213	CbGeAlD
Donepezil—ACHE—cerebellum—multiple sclerosis	0.00191	0.0169	CbGeAlD
Donepezil—SIGMAR1—medulla oblongata—multiple sclerosis	0.00182	0.016	CbGeAlD
Donepezil—SIGMAR1—midbrain—multiple sclerosis	0.00166	0.0147	CbGeAlD
Donepezil—SIGMAR1—spinal cord—multiple sclerosis	0.00162	0.0143	CbGeAlD
Donepezil—ACHE—brain—multiple sclerosis	0.00156	0.0137	CbGeAlD
Donepezil—HTR2A—brainstem—multiple sclerosis	0.00139	0.0123	CbGeAlD
Donepezil—HTR2A—retina—multiple sclerosis	0.00134	0.0118	CbGeAlD
Donepezil—SIGMAR1—cerebellum—multiple sclerosis	0.00128	0.0113	CbGeAlD
Donepezil—CYP2D6—brainstem—multiple sclerosis	0.00126	0.0112	CbGeAlD
Donepezil—SIGMAR1—brain—multiple sclerosis	0.00104	0.00921	CbGeAlD
Donepezil—HTR2A—medulla oblongata—multiple sclerosis	0.000968	0.00855	CbGeAlD
Donepezil—HTR2A—midbrain—multiple sclerosis	0.000885	0.00781	CbGeAlD
Donepezil—HTR2A—spinal cord—multiple sclerosis	0.000863	0.00762	CbGeAlD
Donepezil—HTR2A—nervous system—multiple sclerosis	0.000727	0.00642	CbGeAlD
Donepezil—HTR2A—central nervous system—multiple sclerosis	0.0007	0.00618	CbGeAlD
Donepezil—HTR2A—cerebellum—multiple sclerosis	0.000684	0.00604	CbGeAlD
Donepezil—CYP3A4—nervous system—multiple sclerosis	0.000673	0.00595	CbGeAlD
Donepezil—CYP2D6—nervous system—multiple sclerosis	0.000662	0.00585	CbGeAlD
Donepezil—CYP3A4—central nervous system—multiple sclerosis	0.000648	0.00572	CbGeAlD
Donepezil—CYP2D6—central nervous system—multiple sclerosis	0.000638	0.00563	CbGeAlD
Donepezil—CYP2D6—cerebellum—multiple sclerosis	0.000623	0.00551	CbGeAlD
Donepezil—HTR2A—brain—multiple sclerosis	0.000556	0.00491	CbGeAlD
Donepezil—CYP2D6—brain—multiple sclerosis	0.000506	0.00447	CbGeAlD
Donepezil—Vertigo—Betamethasone—multiple sclerosis	0.000218	0.000568	CcSEcCtD
Donepezil—Vertigo—Dexamethasone—multiple sclerosis	0.000218	0.000568	CcSEcCtD
Donepezil—Syncope—Betamethasone—multiple sclerosis	0.000218	0.000567	CcSEcCtD
Donepezil—Syncope—Dexamethasone—multiple sclerosis	0.000218	0.000567	CcSEcCtD
Donepezil—Arrhythmia—Prednisone—multiple sclerosis	0.000217	0.000565	CcSEcCtD
Donepezil—Infection—Triamcinolone—multiple sclerosis	0.000217	0.000565	CcSEcCtD
Donepezil—Sweating—Methotrexate—multiple sclerosis	0.000217	0.000564	CcSEcCtD
Donepezil—Infection—Methylprednisolone—multiple sclerosis	0.000216	0.000563	CcSEcCtD
Donepezil—Haematuria—Methotrexate—multiple sclerosis	0.000216	0.000561	CcSEcCtD
Donepezil—Shock—Triamcinolone—multiple sclerosis	0.000215	0.000559	CcSEcCtD
Donepezil—Insomnia—Prednisolone—multiple sclerosis	0.000215	0.000559	CcSEcCtD
Donepezil—Alopecia—Prednisone—multiple sclerosis	0.000215	0.000559	CcSEcCtD
Donepezil—Shock—Methylprednisolone—multiple sclerosis	0.000214	0.000558	CcSEcCtD
Donepezil—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000214	0.000556	CcSEcCtD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.000213	0.00282	CbGpPWpGaD
Donepezil—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000213	0.000555	CcSEcCtD
Donepezil—Loss of consciousness—Betamethasone—multiple sclerosis	0.000213	0.000555	CcSEcCtD
Donepezil—Epistaxis—Methotrexate—multiple sclerosis	0.000213	0.000555	CcSEcCtD
Donepezil—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000213	0.000555	CcSEcCtD
Donepezil—Paraesthesia—Prednisolone—multiple sclerosis	0.000213	0.000555	CcSEcCtD
Donepezil—Mental disorder—Prednisone—multiple sclerosis	0.000213	0.000554	CcSEcCtD
Donepezil—Nausea—Azathioprine—multiple sclerosis	0.000213	0.000554	CcSEcCtD
Donepezil—Malnutrition—Prednisone—multiple sclerosis	0.000211	0.00055	CcSEcCtD
Donepezil—Erythema—Prednisone—multiple sclerosis	0.000211	0.00055	CcSEcCtD
Donepezil—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000211	0.00055	CcSEcCtD
Donepezil—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000211	0.000548	CcSEcCtD
Donepezil—Convulsion—Betamethasone—multiple sclerosis	0.00021	0.000548	CcSEcCtD
Donepezil—Convulsion—Dexamethasone—multiple sclerosis	0.00021	0.000548	CcSEcCtD
Donepezil—Hypertension—Dexamethasone—multiple sclerosis	0.00021	0.000546	CcSEcCtD
Donepezil—Hypertension—Betamethasone—multiple sclerosis	0.00021	0.000546	CcSEcCtD
Donepezil—Asthenia—Mitoxantrone—multiple sclerosis	0.000208	0.000541	CcSEcCtD
Donepezil—Myalgia—Dexamethasone—multiple sclerosis	0.000207	0.000538	CcSEcCtD
Donepezil—Myalgia—Betamethasone—multiple sclerosis	0.000207	0.000538	CcSEcCtD
Donepezil—Anxiety—Dexamethasone—multiple sclerosis	0.000206	0.000536	CcSEcCtD
Donepezil—Anxiety—Betamethasone—multiple sclerosis	0.000206	0.000536	CcSEcCtD
Donepezil—Discomfort—Dexamethasone—multiple sclerosis	0.000204	0.000532	CcSEcCtD
Donepezil—Discomfort—Betamethasone—multiple sclerosis	0.000204	0.000532	CcSEcCtD
Donepezil—HTR2A—GPCRs, Other—CCR5—multiple sclerosis	0.000204	0.0027	CbGpPWpGaD
Donepezil—Haemoglobin—Methotrexate—multiple sclerosis	0.000204	0.000531	CcSEcCtD
Donepezil—Hypotension—Methylprednisolone—multiple sclerosis	0.000204	0.00053	CcSEcCtD
Donepezil—Pain—Prednisolone—multiple sclerosis	0.000203	0.000529	CcSEcCtD
Donepezil—Haemorrhage—Methotrexate—multiple sclerosis	0.000203	0.000528	CcSEcCtD
Donepezil—Hepatitis—Methotrexate—multiple sclerosis	0.000203	0.000528	CcSEcCtD
Donepezil—Pharyngitis—Methotrexate—multiple sclerosis	0.000201	0.000524	CcSEcCtD
Donepezil—Urinary tract disorder—Methotrexate—multiple sclerosis	0.0002	0.000522	CcSEcCtD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.0002	0.00264	CbGpPWpGaD
Donepezil—Vision blurred—Prednisone—multiple sclerosis	0.000199	0.000519	CcSEcCtD
Donepezil—Urethral disorder—Methotrexate—multiple sclerosis	0.000199	0.000518	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000199	0.000518	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000198	0.000517	CcSEcCtD
Donepezil—Oedema—Dexamethasone—multiple sclerosis	0.000198	0.000516	CcSEcCtD
Donepezil—Oedema—Betamethasone—multiple sclerosis	0.000198	0.000516	CcSEcCtD
Donepezil—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000198	0.000516	CcSEcCtD
Donepezil—HRH3—Signaling Pathways—TAGAP—multiple sclerosis	0.000198	0.00262	CbGpPWpGaD
Donepezil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000198	0.00261	CbGpPWpGaD
Donepezil—Insomnia—Triamcinolone—multiple sclerosis	0.000197	0.000514	CcSEcCtD
Donepezil—Insomnia—Methylprednisolone—multiple sclerosis	0.000197	0.000513	CcSEcCtD
Donepezil—Infection—Dexamethasone—multiple sclerosis	0.000197	0.000512	CcSEcCtD
Donepezil—Infection—Betamethasone—multiple sclerosis	0.000197	0.000512	CcSEcCtD
Donepezil—Ill-defined disorder—Prednisone—multiple sclerosis	0.000196	0.000511	CcSEcCtD
Donepezil—Paraesthesia—Triamcinolone—multiple sclerosis	0.000196	0.00051	CcSEcCtD
Donepezil—Feeling abnormal—Prednisolone—multiple sclerosis	0.000196	0.000509	CcSEcCtD
Donepezil—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000196	0.000509	CcSEcCtD
Donepezil—Visual impairment—Methotrexate—multiple sclerosis	0.000196	0.000509	CcSEcCtD
Donepezil—Anaemia—Prednisone—multiple sclerosis	0.000195	0.000509	CcSEcCtD
Donepezil—Shock—Betamethasone—multiple sclerosis	0.000195	0.000507	CcSEcCtD
Donepezil—Shock—Dexamethasone—multiple sclerosis	0.000195	0.000507	CcSEcCtD
Donepezil—Dyspnoea—Triamcinolone—multiple sclerosis	0.000195	0.000507	CcSEcCtD
Donepezil—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000194	0.000506	CcSEcCtD
Donepezil—Nervous system disorder—Betamethasone—multiple sclerosis	0.000194	0.000506	CcSEcCtD
Donepezil—Agitation—Prednisone—multiple sclerosis	0.000194	0.000506	CcSEcCtD
Donepezil—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000194	0.000505	CcSEcCtD
Donepezil—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000194	0.000505	CcSEcCtD
Donepezil—HRH3—GPCR ligand binding—CCL5—multiple sclerosis	0.000194	0.00256	CbGpPWpGaD
Donepezil—Dyspepsia—Triamcinolone—multiple sclerosis	0.000192	0.0005	CcSEcCtD
Donepezil—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000192	0.000499	CcSEcCtD
Donepezil—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000191	0.000499	CcSEcCtD
Donepezil—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000191	0.000499	CcSEcCtD
Donepezil—Malaise—Prednisone—multiple sclerosis	0.000191	0.000496	CcSEcCtD
Donepezil—Vertigo—Prednisone—multiple sclerosis	0.00019	0.000494	CcSEcCtD
Donepezil—Syncope—Prednisone—multiple sclerosis	0.00019	0.000494	CcSEcCtD
Donepezil—Tinnitus—Methotrexate—multiple sclerosis	0.000189	0.000493	CcSEcCtD
Donepezil—HTR2A—GPCR ligand binding—S1PR1—multiple sclerosis	0.000189	0.0025	CbGpPWpGaD
Donepezil—Anorexia—Betamethasone—multiple sclerosis	0.000189	0.000492	CcSEcCtD
Donepezil—Anorexia—Dexamethasone—multiple sclerosis	0.000189	0.000492	CcSEcCtD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.000189	0.0025	CbGpPWpGaD
Donepezil—Urticaria—Prednisolone—multiple sclerosis	0.000189	0.000491	CcSEcCtD
Donepezil—Fatigue—Triamcinolone—multiple sclerosis	0.000188	0.00049	CcSEcCtD
Donepezil—Fatigue—Methylprednisolone—multiple sclerosis	0.000188	0.000489	CcSEcCtD
Donepezil—Pain—Triamcinolone—multiple sclerosis	0.000187	0.000486	CcSEcCtD
Donepezil—Loss of consciousness—Prednisone—multiple sclerosis	0.000186	0.000484	CcSEcCtD
Donepezil—Hypotension—Betamethasone—multiple sclerosis	0.000185	0.000482	CcSEcCtD
Donepezil—Hypotension—Dexamethasone—multiple sclerosis	0.000185	0.000482	CcSEcCtD
Donepezil—ACHE—ATF-2 transcription factor network—MAPK1—multiple sclerosis	0.000184	0.00244	CbGpPWpGaD
Donepezil—Vomiting—Mitoxantrone—multiple sclerosis	0.000184	0.000479	CcSEcCtD
Donepezil—Convulsion—Prednisone—multiple sclerosis	0.000183	0.000477	CcSEcCtD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.000183	0.00242	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.000183	0.00242	CbGpPWpGaD
Donepezil—Hypertension—Prednisone—multiple sclerosis	0.000182	0.000475	CcSEcCtD
Donepezil—Rash—Mitoxantrone—multiple sclerosis	0.000182	0.000475	CcSEcCtD
Donepezil—Dermatitis—Mitoxantrone—multiple sclerosis	0.000182	0.000475	CcSEcCtD
Donepezil—Chills—Methotrexate—multiple sclerosis	0.000182	0.000474	CcSEcCtD
Donepezil—ACHE—Neuronal System—BCHE—multiple sclerosis	0.000182	0.00241	CbGpPWpGaD
Donepezil—Headache—Mitoxantrone—multiple sclerosis	0.000181	0.000472	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00018	0.00047	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00018	0.00047	CcSEcCtD
Donepezil—Arthralgia—Prednisone—multiple sclerosis	0.00018	0.000469	CcSEcCtD
Donepezil—Myalgia—Prednisone—multiple sclerosis	0.00018	0.000469	CcSEcCtD
Donepezil—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00018	0.000468	CcSEcCtD
Donepezil—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000179	0.000467	CcSEcCtD
Donepezil—Anxiety—Prednisone—multiple sclerosis	0.000179	0.000467	CcSEcCtD
Donepezil—Alopecia—Methotrexate—multiple sclerosis	0.000179	0.000467	CcSEcCtD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000179	0.00237	CbGpPWpGaD
Donepezil—Insomnia—Betamethasone—multiple sclerosis	0.000179	0.000466	CcSEcCtD
Donepezil—Insomnia—Dexamethasone—multiple sclerosis	0.000179	0.000466	CcSEcCtD
Donepezil—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000178	0.000464	CcSEcCtD
Donepezil—Paraesthesia—Betamethasone—multiple sclerosis	0.000178	0.000463	CcSEcCtD
Donepezil—Paraesthesia—Dexamethasone—multiple sclerosis	0.000178	0.000463	CcSEcCtD
Donepezil—Discomfort—Prednisone—multiple sclerosis	0.000178	0.000463	CcSEcCtD
Donepezil—Mental disorder—Methotrexate—multiple sclerosis	0.000178	0.000463	CcSEcCtD
Donepezil—Erythema—Methotrexate—multiple sclerosis	0.000177	0.00046	CcSEcCtD
Donepezil—Malnutrition—Methotrexate—multiple sclerosis	0.000177	0.00046	CcSEcCtD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000175	0.00232	CbGpPWpGaD
Donepezil—Hypersensitivity—Prednisolone—multiple sclerosis	0.000175	0.000455	CcSEcCtD
Donepezil—HRH3—GPCR ligand binding—CCR5—multiple sclerosis	0.000175	0.00231	CbGpPWpGaD
Donepezil—Dyspepsia—Betamethasone—multiple sclerosis	0.000174	0.000454	CcSEcCtD
Donepezil—Dyspepsia—Dexamethasone—multiple sclerosis	0.000174	0.000454	CcSEcCtD
Donepezil—Urticaria—Triamcinolone—multiple sclerosis	0.000173	0.000452	CcSEcCtD
Donepezil—Urticaria—Methylprednisolone—multiple sclerosis	0.000173	0.000451	CcSEcCtD
Donepezil—Dysgeusia—Methotrexate—multiple sclerosis	0.000173	0.00045	CcSEcCtD
Donepezil—HRH3—Signaling Pathways—S1PR1—multiple sclerosis	0.000173	0.00229	CbGpPWpGaD
Donepezil—Body temperature increased—Triamcinolone—multiple sclerosis	0.000173	0.000449	CcSEcCtD
Donepezil—Oedema—Prednisone—multiple sclerosis	0.000172	0.000449	CcSEcCtD
Donepezil—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000172	0.000448	CcSEcCtD
Donepezil—Decreased appetite—Dexamethasone—multiple sclerosis	0.000172	0.000448	CcSEcCtD
Donepezil—Decreased appetite—Betamethasone—multiple sclerosis	0.000172	0.000448	CcSEcCtD
Donepezil—Nausea—Mitoxantrone—multiple sclerosis	0.000172	0.000448	CcSEcCtD
Donepezil—Infection—Prednisone—multiple sclerosis	0.000171	0.000446	CcSEcCtD
Donepezil—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000171	0.000445	CcSEcCtD
Donepezil—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000171	0.000445	CcSEcCtD
Donepezil—Back pain—Methotrexate—multiple sclerosis	0.000171	0.000445	CcSEcCtD
Donepezil—Fatigue—Betamethasone—multiple sclerosis	0.000171	0.000445	CcSEcCtD
Donepezil—Fatigue—Dexamethasone—multiple sclerosis	0.000171	0.000445	CcSEcCtD
Donepezil—Shock—Prednisone—multiple sclerosis	0.00017	0.000442	CcSEcCtD
Donepezil—Pain—Dexamethasone—multiple sclerosis	0.000169	0.000441	CcSEcCtD
Donepezil—Pain—Betamethasone—multiple sclerosis	0.000169	0.000441	CcSEcCtD
Donepezil—Nervous system disorder—Prednisone—multiple sclerosis	0.000169	0.00044	CcSEcCtD
Donepezil—HRH3—Signaling Pathways—GPC5—multiple sclerosis	0.000168	0.00222	CbGpPWpGaD
Donepezil—Hyperhidrosis—Prednisone—multiple sclerosis	0.000167	0.000434	CcSEcCtD
Donepezil—ACHE—Metabolism of proteins—SLC30A7—multiple sclerosis	0.000167	0.0022	CbGpPWpGaD
Donepezil—Vision blurred—Methotrexate—multiple sclerosis	0.000166	0.000433	CcSEcCtD
Donepezil—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000165	0.00218	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000165	0.00218	CbGpPWpGaD
Donepezil—Anorexia—Prednisone—multiple sclerosis	0.000164	0.000428	CcSEcCtD
Donepezil—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000164	0.000427	CcSEcCtD
Donepezil—Anaemia—Methotrexate—multiple sclerosis	0.000163	0.000425	CcSEcCtD
Donepezil—Feeling abnormal—Betamethasone—multiple sclerosis	0.000163	0.000425	CcSEcCtD
Donepezil—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000163	0.000425	CcSEcCtD
Donepezil—HRH3—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000163	0.00216	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000163	0.00215	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000163	0.00215	CbGpPWpGaD
Donepezil—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000162	0.000422	CcSEcCtD
Donepezil—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000162	0.000422	CcSEcCtD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000162	0.00214	CbGpPWpGaD
Donepezil—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000161	0.000419	CcSEcCtD
Donepezil—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00016	0.000418	CcSEcCtD
Donepezil—Malaise—Methotrexate—multiple sclerosis	0.000159	0.000415	CcSEcCtD
Donepezil—Vertigo—Methotrexate—multiple sclerosis	0.000159	0.000413	CcSEcCtD
Donepezil—HRH3—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000157	0.00208	CbGpPWpGaD
Donepezil—Urticaria—Betamethasone—multiple sclerosis	0.000157	0.00041	CcSEcCtD
Donepezil—Urticaria—Dexamethasone—multiple sclerosis	0.000157	0.00041	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000157	0.000409	CcSEcCtD
Donepezil—Dizziness—Prednisolone—multiple sclerosis	0.000157	0.000409	CcSEcCtD
Donepezil—Asthenia—Triamcinolone—multiple sclerosis	0.000157	0.000408	CcSEcCtD
Donepezil—Abdominal pain—Betamethasone—multiple sclerosis	0.000157	0.000408	CcSEcCtD
Donepezil—Body temperature increased—Betamethasone—multiple sclerosis	0.000157	0.000408	CcSEcCtD
Donepezil—Body temperature increased—Dexamethasone—multiple sclerosis	0.000157	0.000408	CcSEcCtD
Donepezil—Abdominal pain—Dexamethasone—multiple sclerosis	0.000157	0.000408	CcSEcCtD
Donepezil—Asthenia—Methylprednisolone—multiple sclerosis	0.000156	0.000407	CcSEcCtD
Donepezil—Insomnia—Prednisone—multiple sclerosis	0.000156	0.000406	CcSEcCtD
Donepezil—Paraesthesia—Prednisone—multiple sclerosis	0.000155	0.000403	CcSEcCtD
Donepezil—Pruritus—Triamcinolone—multiple sclerosis	0.000154	0.000402	CcSEcCtD
Donepezil—Cough—Methotrexate—multiple sclerosis	0.000154	0.000401	CcSEcCtD
Donepezil—Pruritus—Methylprednisolone—multiple sclerosis	0.000154	0.000401	CcSEcCtD
Donepezil—HRH3—Signaling by GPCR—CCL3—multiple sclerosis	0.000154	0.00203	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000154	0.00203	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—CCR2—multiple sclerosis	0.000153	0.00203	CbGpPWpGaD
Donepezil—Convulsion—Methotrexate—multiple sclerosis	0.000153	0.000399	CcSEcCtD
Donepezil—HTR2A—GPCR ligand binding—GPR65—multiple sclerosis	0.000152	0.00201	CbGpPWpGaD
Donepezil—Dyspepsia—Prednisone—multiple sclerosis	0.000152	0.000395	CcSEcCtD
Donepezil—Myalgia—Methotrexate—multiple sclerosis	0.00015	0.000392	CcSEcCtD
Donepezil—Chest pain—Methotrexate—multiple sclerosis	0.00015	0.000392	CcSEcCtD
Donepezil—Arthralgia—Methotrexate—multiple sclerosis	0.00015	0.000392	CcSEcCtD
Donepezil—Decreased appetite—Prednisone—multiple sclerosis	0.00015	0.00039	CcSEcCtD
Donepezil—Rash—Prednisolone—multiple sclerosis	0.00015	0.00039	CcSEcCtD
Donepezil—Dermatitis—Prednisolone—multiple sclerosis	0.00015	0.000389	CcSEcCtD
Donepezil—ACHE—Metabolism—SRM—multiple sclerosis	0.000149	0.00198	CbGpPWpGaD
Donepezil—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000149	0.000388	CcSEcCtD
Donepezil—Fatigue—Prednisone—multiple sclerosis	0.000149	0.000387	CcSEcCtD
Donepezil—Headache—Prednisolone—multiple sclerosis	0.000149	0.000387	CcSEcCtD
Donepezil—Discomfort—Methotrexate—multiple sclerosis	0.000149	0.000387	CcSEcCtD
Donepezil—HRH3—Signaling by GPCR—PTGER4—multiple sclerosis	0.000148	0.00196	CbGpPWpGaD
Donepezil—Constipation—Prednisone—multiple sclerosis	0.000148	0.000384	CcSEcCtD
Donepezil—HRH3—Signaling Pathways—RGS1—multiple sclerosis	0.000147	0.00194	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000147	0.00194	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.000146	0.00194	CbGpPWpGaD
Donepezil—Confusional state—Methotrexate—multiple sclerosis	0.000145	0.000379	CcSEcCtD
Donepezil—Dizziness—Triamcinolone—multiple sclerosis	0.000144	0.000376	CcSEcCtD
Donepezil—Dizziness—Methylprednisolone—multiple sclerosis	0.000144	0.000375	CcSEcCtD
Donepezil—Infection—Methotrexate—multiple sclerosis	0.000143	0.000373	CcSEcCtD
Donepezil—HRH3—Signaling by GPCR—CXCR3—multiple sclerosis	0.000143	0.00189	CbGpPWpGaD
Donepezil—Feeling abnormal—Prednisone—multiple sclerosis	0.000142	0.00037	CcSEcCtD
Donepezil—Asthenia—Dexamethasone—multiple sclerosis	0.000142	0.00037	CcSEcCtD
Donepezil—Asthenia—Betamethasone—multiple sclerosis	0.000142	0.00037	CcSEcCtD
Donepezil—ACHE—ATF-2 transcription factor network—IL6—multiple sclerosis	0.000142	0.00187	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.000141	0.00187	CbGpPWpGaD
Donepezil—Nervous system disorder—Methotrexate—multiple sclerosis	0.000141	0.000368	CcSEcCtD
Donepezil—HRH3—GPCR downstream signaling—CNR1—multiple sclerosis	0.000141	0.00187	CbGpPWpGaD
Donepezil—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000141	0.000368	CcSEcCtD
Donepezil—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000141	0.000367	CcSEcCtD
Donepezil—Nausea—Prednisolone—multiple sclerosis	0.000141	0.000367	CcSEcCtD
Donepezil—Pruritus—Betamethasone—multiple sclerosis	0.00014	0.000365	CcSEcCtD
Donepezil—Pruritus—Dexamethasone—multiple sclerosis	0.00014	0.000365	CcSEcCtD
Donepezil—HRH3—Signaling Pathways—GPR65—multiple sclerosis	0.000139	0.00184	CbGpPWpGaD
Donepezil—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000139	0.000363	CcSEcCtD
Donepezil—HTR2A—GPCR ligand binding—CCR1—multiple sclerosis	0.000139	0.00184	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—CXCL13—multiple sclerosis	0.000139	0.00184	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—CCR2—multiple sclerosis	0.000139	0.00184	CbGpPWpGaD
Donepezil—Vomiting—Triamcinolone—multiple sclerosis	0.000139	0.000361	CcSEcCtD
Donepezil—Vomiting—Methylprednisolone—multiple sclerosis	0.000138	0.000361	CcSEcCtD
Donepezil—Rash—Triamcinolone—multiple sclerosis	0.000138	0.000358	CcSEcCtD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.000138	0.00182	CbGpPWpGaD
Donepezil—Dermatitis—Triamcinolone—multiple sclerosis	0.000138	0.000358	CcSEcCtD
Donepezil—Anorexia—Methotrexate—multiple sclerosis	0.000137	0.000358	CcSEcCtD
Donepezil—Rash—Methylprednisolone—multiple sclerosis	0.000137	0.000358	CcSEcCtD
Donepezil—Dermatitis—Methylprednisolone—multiple sclerosis	0.000137	0.000357	CcSEcCtD
Donepezil—Urticaria—Prednisone—multiple sclerosis	0.000137	0.000357	CcSEcCtD
Donepezil—Headache—Triamcinolone—multiple sclerosis	0.000137	0.000356	CcSEcCtD
Donepezil—HRH3—GPCR ligand binding—POMC—multiple sclerosis	0.000137	0.0018	CbGpPWpGaD
Donepezil—Headache—Methylprednisolone—multiple sclerosis	0.000136	0.000355	CcSEcCtD
Donepezil—Abdominal pain—Prednisone—multiple sclerosis	0.000136	0.000355	CcSEcCtD
Donepezil—Body temperature increased—Prednisone—multiple sclerosis	0.000136	0.000355	CcSEcCtD
Donepezil—Diarrhoea—Betamethasone—multiple sclerosis	0.000136	0.000353	CcSEcCtD
Donepezil—Diarrhoea—Dexamethasone—multiple sclerosis	0.000136	0.000353	CcSEcCtD
Donepezil—Hypotension—Methotrexate—multiple sclerosis	0.000135	0.000351	CcSEcCtD
Donepezil—ACHE—Metabolism of proteins—PABPC1—multiple sclerosis	0.000135	0.00178	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—CCL2—multiple sclerosis	0.000134	0.00177	CbGpPWpGaD
Donepezil—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000132	0.00174	CbGpPWpGaD
Donepezil—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000131	0.000342	CcSEcCtD
Donepezil—Dizziness—Dexamethasone—multiple sclerosis	0.000131	0.000341	CcSEcCtD
Donepezil—Dizziness—Betamethasone—multiple sclerosis	0.000131	0.000341	CcSEcCtD
Donepezil—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000131	0.00173	CbGpPWpGaD
Donepezil—Insomnia—Methotrexate—multiple sclerosis	0.00013	0.00034	CcSEcCtD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.00013	0.00172	CbGpPWpGaD
Donepezil—Nausea—Triamcinolone—multiple sclerosis	0.00013	0.000338	CcSEcCtD
Donepezil—Paraesthesia—Methotrexate—multiple sclerosis	0.000129	0.000337	CcSEcCtD
Donepezil—Nausea—Methylprednisolone—multiple sclerosis	0.000129	0.000337	CcSEcCtD
Donepezil—Dyspnoea—Methotrexate—multiple sclerosis	0.000129	0.000335	CcSEcCtD
Donepezil—HRH3—Signaling by GPCR—CNR1—multiple sclerosis	0.000128	0.0017	CbGpPWpGaD
Donepezil—Somnolence—Methotrexate—multiple sclerosis	0.000128	0.000334	CcSEcCtD
Donepezil—HRH3—Signaling Pathways—CCR1—multiple sclerosis	0.000128	0.00169	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CXCL13—multiple sclerosis	0.000128	0.00169	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000127	0.00168	CbGpPWpGaD
Donepezil—Hypersensitivity—Prednisone—multiple sclerosis	0.000127	0.000331	CcSEcCtD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.000127	0.00168	CbGpPWpGaD
Donepezil—Dyspepsia—Methotrexate—multiple sclerosis	0.000127	0.00033	CcSEcCtD
Donepezil—Vomiting—Betamethasone—multiple sclerosis	0.000126	0.000328	CcSEcCtD
Donepezil—Vomiting—Dexamethasone—multiple sclerosis	0.000126	0.000328	CcSEcCtD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.000125	0.00166	CbGpPWpGaD
Donepezil—Decreased appetite—Methotrexate—multiple sclerosis	0.000125	0.000326	CcSEcCtD
Donepezil—Rash—Dexamethasone—multiple sclerosis	0.000125	0.000325	CcSEcCtD
Donepezil—Rash—Betamethasone—multiple sclerosis	0.000125	0.000325	CcSEcCtD
Donepezil—Dermatitis—Dexamethasone—multiple sclerosis	0.000125	0.000325	CcSEcCtD
Donepezil—Dermatitis—Betamethasone—multiple sclerosis	0.000125	0.000325	CcSEcCtD
Donepezil—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000124	0.000324	CcSEcCtD
Donepezil—Fatigue—Methotrexate—multiple sclerosis	0.000124	0.000324	CcSEcCtD
Donepezil—Headache—Dexamethasone—multiple sclerosis	0.000124	0.000323	CcSEcCtD
Donepezil—Headache—Betamethasone—multiple sclerosis	0.000124	0.000323	CcSEcCtD
Donepezil—Asthenia—Prednisone—multiple sclerosis	0.000124	0.000322	CcSEcCtD
Donepezil—Pain—Methotrexate—multiple sclerosis	0.000123	0.000321	CcSEcCtD
Donepezil—Pruritus—Prednisone—multiple sclerosis	0.000122	0.000318	CcSEcCtD
Donepezil—ACHE—Metabolism of proteins—RPL5—multiple sclerosis	0.000121	0.00161	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000121	0.0016	CbGpPWpGaD
Donepezil—Feeling abnormal—Methotrexate—multiple sclerosis	0.000119	0.000309	CcSEcCtD
Donepezil—Diarrhoea—Prednisone—multiple sclerosis	0.000118	0.000307	CcSEcCtD
Donepezil—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000118	0.000307	CcSEcCtD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000118	0.00156	CbGpPWpGaD
Donepezil—Nausea—Betamethasone—multiple sclerosis	0.000118	0.000306	CcSEcCtD
Donepezil—Nausea—Dexamethasone—multiple sclerosis	0.000118	0.000306	CcSEcCtD
Donepezil—HRH3—Signaling by GPCR—CXCL10—multiple sclerosis	0.000116	0.00153	CbGpPWpGaD
Donepezil—Urticaria—Methotrexate—multiple sclerosis	0.000115	0.000298	CcSEcCtD
Donepezil—Dizziness—Prednisone—multiple sclerosis	0.000114	0.000297	CcSEcCtD
Donepezil—Body temperature increased—Methotrexate—multiple sclerosis	0.000114	0.000297	CcSEcCtD
Donepezil—Abdominal pain—Methotrexate—multiple sclerosis	0.000114	0.000297	CcSEcCtD
Donepezil—Vomiting—Prednisone—multiple sclerosis	0.00011	0.000286	CcSEcCtD
Donepezil—HRH3—GPCR downstream signaling—CCL5—multiple sclerosis	0.00011	0.00145	CbGpPWpGaD
Donepezil—Rash—Prednisone—multiple sclerosis	0.000109	0.000283	CcSEcCtD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000109	0.00144	CbGpPWpGaD
Donepezil—Dermatitis—Prednisone—multiple sclerosis	0.000109	0.000283	CcSEcCtD
Donepezil—Headache—Prednisone—multiple sclerosis	0.000108	0.000281	CcSEcCtD
Donepezil—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000107	0.00141	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000107	0.00141	CbGpPWpGaD
Donepezil—Hypersensitivity—Methotrexate—multiple sclerosis	0.000106	0.000277	CcSEcCtD
Donepezil—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000106	0.0014	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CYP27B1—multiple sclerosis	0.000105	0.00139	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CYP24A1—multiple sclerosis	0.000105	0.00139	CbGpPWpGaD
Donepezil—Asthenia—Methotrexate—multiple sclerosis	0.000103	0.000269	CcSEcCtD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000103	0.00136	CbGpPWpGaD
Donepezil—Nausea—Prednisone—multiple sclerosis	0.000102	0.000267	CcSEcCtD
Donepezil—Pruritus—Methotrexate—multiple sclerosis	0.000102	0.000266	CcSEcCtD
Donepezil—HRH3—Signaling by GPCR—CCL5—multiple sclerosis	9.95e-05	0.00132	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—CCL3—multiple sclerosis	9.92e-05	0.00131	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—CCR5—multiple sclerosis	9.87e-05	0.0013	CbGpPWpGaD
Donepezil—Diarrhoea—Methotrexate—multiple sclerosis	9.86e-05	0.000257	CcSEcCtD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	9.79e-05	0.00129	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—IL2RA—multiple sclerosis	9.73e-05	0.00129	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—S1PR1—multiple sclerosis	9.69e-05	0.00128	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GPC5—multiple sclerosis	9.63e-05	0.00127	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	9.61e-05	0.00127	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	9.61e-05	0.00127	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—PTGER4—multiple sclerosis	9.55e-05	0.00126	CbGpPWpGaD
Donepezil—Dizziness—Methotrexate—multiple sclerosis	9.53e-05	0.000248	CcSEcCtD
Donepezil—HTR2A—GPCR ligand binding—CXCR3—multiple sclerosis	9.22e-05	0.00122	CbGpPWpGaD
Donepezil—Vomiting—Methotrexate—multiple sclerosis	9.17e-05	0.000239	CcSEcCtD
Donepezil—Rash—Methotrexate—multiple sclerosis	9.09e-05	0.000237	CcSEcCtD
Donepezil—HRH3—Signaling Pathways—CCL3—multiple sclerosis	9.09e-05	0.0012	CbGpPWpGaD
Donepezil—Dermatitis—Methotrexate—multiple sclerosis	9.08e-05	0.000236	CcSEcCtD
Donepezil—HTR2A—GPCR downstream signaling—RGS1—multiple sclerosis	9.08e-05	0.0012	CbGpPWpGaD
Donepezil—Headache—Methotrexate—multiple sclerosis	9.03e-05	0.000235	CcSEcCtD
Donepezil—HTR2A—GPCR ligand binding—CCR2—multiple sclerosis	8.97e-05	0.00119	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—CCR5—multiple sclerosis	8.96e-05	0.00119	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—BCHE—multiple sclerosis	8.89e-05	0.00118	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	8.86e-05	0.00117	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—IL2RA—multiple sclerosis	8.83e-05	0.00117	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PTGER4—multiple sclerosis	8.75e-05	0.00116	CbGpPWpGaD
Donepezil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.62e-05	0.00114	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PGR—multiple sclerosis	8.61e-05	0.00114	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—GPR65—multiple sclerosis	8.6e-05	0.00114	CbGpPWpGaD
Donepezil—Nausea—Methotrexate—multiple sclerosis	8.56e-05	0.000223	CcSEcCtD
Donepezil—HRH3—Signaling Pathways—CXCR3—multiple sclerosis	8.45e-05	0.00112	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	8.43e-05	0.00111	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CD28—multiple sclerosis	8.37e-05	0.00111	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—CNR1—multiple sclerosis	8.28e-05	0.00109	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—RGS1—multiple sclerosis	8.24e-05	0.00109	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CCR2—multiple sclerosis	8.22e-05	0.00109	CbGpPWpGaD
Donepezil—ACHE—Metabolism—RRM1—multiple sclerosis	7.98e-05	0.00105	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CXCL13—multiple sclerosis	7.87e-05	0.00104	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CCR1—multiple sclerosis	7.87e-05	0.00104	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—GPR65—multiple sclerosis	7.81e-05	0.00103	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—POMC—multiple sclerosis	7.71e-05	0.00102	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	7.69e-05	0.00102	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	7.59e-05	0.001	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CNR1—multiple sclerosis	7.58e-05	0.001	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—LINGO1—multiple sclerosis	7.56e-05	0.000999	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—CXCL10—multiple sclerosis	7.46e-05	0.000986	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	7.36e-05	0.000973	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	7.34e-05	0.000971	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	7.2e-05	0.000952	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CXCL13—multiple sclerosis	7.15e-05	0.000945	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CCR1—multiple sclerosis	7.15e-05	0.000945	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	7.12e-05	0.000941	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—POMC—multiple sclerosis	7.01e-05	0.000926	CbGpPWpGaD
Donepezil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.99e-05	0.000924	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	6.94e-05	0.000918	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	6.86e-05	0.000907	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—CCL2—multiple sclerosis	6.85e-05	0.000906	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CXCL10—multiple sclerosis	6.83e-05	0.000903	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TAGAP—multiple sclerosis	6.55e-05	0.000866	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—CCL5—multiple sclerosis	6.42e-05	0.000849	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—TYK2—multiple sclerosis	6.22e-05	0.000823	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.19e-05	0.000818	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SRM—multiple sclerosis	6.13e-05	0.00081	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SRM—multiple sclerosis	6.08e-05	0.000803	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CD86—multiple sclerosis	5.97e-05	0.000789	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	5.93e-05	0.000785	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CCL5—multiple sclerosis	5.88e-05	0.000777	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	5.81e-05	0.000768	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—CCR5—multiple sclerosis	5.78e-05	0.000764	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—S1PR1—multiple sclerosis	5.73e-05	0.000757	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—IL2—multiple sclerosis	5.7e-05	0.000754	CbGpPWpGaD
Donepezil—CYP2D6—Biological oxidations—POMC—multiple sclerosis	5.68e-05	0.000751	CbGpPWpGaD
Donepezil—CYP2C9—Biological oxidations—POMC—multiple sclerosis	5.63e-05	0.000744	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	5.58e-05	0.000737	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GPC5—multiple sclerosis	5.57e-05	0.000736	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—SPP1—multiple sclerosis	5.44e-05	0.00072	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PTGER4—multiple sclerosis	5.4e-05	0.000714	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—MAPK1—multiple sclerosis	5.32e-05	0.000703	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.32e-05	0.000703	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CCR5—multiple sclerosis	5.29e-05	0.0007	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IL2RA—multiple sclerosis	5.22e-05	0.00069	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CXCR3—multiple sclerosis	5.21e-05	0.000689	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—IL2—multiple sclerosis	5.18e-05	0.000685	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CCL3—multiple sclerosis	5.09e-05	0.000673	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CCR2—multiple sclerosis	5.07e-05	0.00067	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PTGER4—multiple sclerosis	4.9e-05	0.000648	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RGS1—multiple sclerosis	4.87e-05	0.000644	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.85e-05	0.000641	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—APOE—multiple sclerosis	4.82e-05	0.000637	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CXCR3—multiple sclerosis	4.73e-05	0.000626	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CNR1—multiple sclerosis	4.68e-05	0.000619	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GPR65—multiple sclerosis	4.62e-05	0.00061	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CCR2—multiple sclerosis	4.6e-05	0.000609	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—POMC—multiple sclerosis	4.59e-05	0.000607	CbGpPWpGaD
Donepezil—ACHE—Metabolism—BCHE—multiple sclerosis	4.58e-05	0.000606	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	4.53e-05	0.000599	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—POMC—multiple sclerosis	4.52e-05	0.000597	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	4.5e-05	0.000595	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—CCL2—multiple sclerosis	4.5e-05	0.000594	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—CCL2—multiple sclerosis	4.42e-05	0.000585	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CD80—multiple sclerosis	4.36e-05	0.000576	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	4.32e-05	0.000571	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	4.32e-05	0.000571	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	4.28e-05	0.000566	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	4.28e-05	0.000566	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CNR1—multiple sclerosis	4.25e-05	0.000562	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CXCL13—multiple sclerosis	4.22e-05	0.000558	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCR1—multiple sclerosis	4.22e-05	0.000558	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CXCL10—multiple sclerosis	4.21e-05	0.000557	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.18e-05	0.000553	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—POMC—multiple sclerosis	4.14e-05	0.000547	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CCL2—multiple sclerosis	4.05e-05	0.000535	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SRM—multiple sclerosis	4.01e-05	0.00053	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—MAPK1—multiple sclerosis	3.96e-05	0.000524	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GPC5—multiple sclerosis	3.95e-05	0.000522	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GPC5—multiple sclerosis	3.92e-05	0.000518	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CXCL10—multiple sclerosis	3.83e-05	0.000506	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.71e-05	0.000491	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TYK2—multiple sclerosis	3.68e-05	0.000486	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CCL5—multiple sclerosis	3.63e-05	0.00048	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	3.48e-05	0.00046	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CCL5—multiple sclerosis	3.29e-05	0.000435	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—RRM1—multiple sclerosis	3.27e-05	0.000433	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CCR5—multiple sclerosis	3.27e-05	0.000432	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—RRM1—multiple sclerosis	3.24e-05	0.000429	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—IL2RA—multiple sclerosis	3.22e-05	0.000426	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IL2—multiple sclerosis	3.06e-05	0.000404	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—IL6—multiple sclerosis	3.04e-05	0.000402	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCL3—multiple sclerosis	3.01e-05	0.000398	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CCR5—multiple sclerosis	2.97e-05	0.000392	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL2RA—multiple sclerosis	2.92e-05	0.000387	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MMP9—multiple sclerosis	2.9e-05	0.000383	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PTGER4—multiple sclerosis	2.9e-05	0.000383	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PGR—multiple sclerosis	2.85e-05	0.000377	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.82e-05	0.000373	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.82e-05	0.000373	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CXCR3—multiple sclerosis	2.8e-05	0.00037	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CD28—multiple sclerosis	2.77e-05	0.000366	CbGpPWpGaD
Donepezil—ACHE—Metabolism—APOE—multiple sclerosis	2.76e-05	0.000364	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCR2—multiple sclerosis	2.72e-05	0.00036	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.58e-05	0.000341	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—STAT3—multiple sclerosis	2.57e-05	0.00034	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—POMC—multiple sclerosis	2.55e-05	0.000338	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.52e-05	0.000333	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CNR1—multiple sclerosis	2.51e-05	0.000332	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MYC—multiple sclerosis	2.39e-05	0.000316	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TGFB1—multiple sclerosis	2.39e-05	0.000316	CbGpPWpGaD
Donepezil—ACHE—Metabolism—POMC—multiple sclerosis	2.37e-05	0.000313	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MAPK1—multiple sclerosis	2.34e-05	0.000309	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—POMC—multiple sclerosis	2.32e-05	0.000307	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CCL2—multiple sclerosis	2.27e-05	0.0003	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CXCL10—multiple sclerosis	2.26e-05	0.000299	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.16e-05	0.000286	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ALB—multiple sclerosis	2.16e-05	0.000285	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.14e-05	0.000283	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—TYK2—multiple sclerosis	2.06e-05	0.000272	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CD86—multiple sclerosis	1.98e-05	0.000261	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.97e-05	0.000261	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCL5—multiple sclerosis	1.95e-05	0.000257	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—IL2—multiple sclerosis	1.89e-05	0.00025	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.88e-05	0.000248	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.86e-05	0.000246	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SPP1—multiple sclerosis	1.8e-05	0.000238	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IL6—multiple sclerosis	1.8e-05	0.000238	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	1.75e-05	0.000232	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	1.73e-05	0.000228	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	1.71e-05	0.000227	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—APOE—multiple sclerosis	1.59e-05	0.000211	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CD80—multiple sclerosis	1.44e-05	0.000191	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—POMC—multiple sclerosis	1.37e-05	0.000181	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	1.34e-05	0.000177	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.31e-05	0.000173	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.23e-05	0.000162	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	1.22e-05	0.000161	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—APOE—multiple sclerosis	1.13e-05	0.000149	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—APOE—multiple sclerosis	1.12e-05	0.000148	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL2—multiple sclerosis	1.01e-05	0.000134	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	1.01e-05	0.000133	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—POMC—multiple sclerosis	9.71e-06	0.000128	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—POMC—multiple sclerosis	9.63e-06	0.000127	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	9.59e-06	0.000127	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALB—multiple sclerosis	8.86e-06	0.000117	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALB—multiple sclerosis	8.78e-06	0.000116	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	8.52e-06	0.000113	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MYC—multiple sclerosis	7.92e-06	0.000105	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	7.9e-06	0.000104	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	7.75e-06	0.000102	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APOE—multiple sclerosis	7.39e-06	9.77e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—POMC—multiple sclerosis	6.35e-06	8.4e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL6—multiple sclerosis	5.95e-06	7.87e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALB—multiple sclerosis	5.79e-06	7.65e-05	CbGpPWpGaD
